Evolving Perspectives on Depression: Chronic vs. Episodic Treatment in MDD and the Role of the GABA System

Thursday, May 11, 2023

11:45 AM – 12:45 PM USA

Presenter(s)

Rakesh Jain, MD

Clinical Professor
Texas Tech - Permian Basin
Texas Tech University School of Medicine - Permian Basin, Midland, Texas
Austin, Texas
Greg Mattingly, MD

Associate Clinical Professor, Washington University in St. Louis; President, Midwest Research Group; Board of Directors, APSARD; Editorial Board, Journal of Attention Disorders
St.Charles Psychiatric Associates
Washington University School of Medicine
St.Charles, Missouri
CM

Cheryl Meier

Patient Advocate
Midwest Research Group
O Fallon, Missouri
Ahmed Baig, MD

Chief Medical Officer
Midwest Research Group
St. Louis, Missouri

Disclosure(s):

Greg Mattingly, MD: No relevant disclosure to display

Cheryl Meier: No financial relationships to disclose

Ahmed Baig, MD: No financial relationships to disclose

Major depressive disorder (MDD) is a highly impairing disorder that can affect many areas of one’s life. Our experts will differentiate the clinical needs associated with episodic versus chronic depression, describe the pathophysiologic role of GABA in neurotransmitter dysfunction among individuals with MDD or postpartum depression (PPD), and share the optimal treatment strategies given the mechanisms of action and latest clinical data associated with antidepressant medications for MDD and PPD. Join our faculty in a live Q&A session immediately following their presentation where they will answer the most popular questions. This activity has been supported through an independent educational grant from Sage Therapeutics, Inc. and Biogen Inc.

Learning Objectives:

Differentiate among the clinical needs associated with episodic versus chronic depression
Summarize the pathophysiologic role of GABA in neurotransmitter dysfunction in patients with MDD or PPD
Implement optimal treatment strategies by considering the mechanisms of action and most recent clinical data associated with antidepressant medications for MDD or PPD
Practice collaborative care and shared decision making when caring for patients with MDD or PPD